✦ LIBER ✦

Erratum to: Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML)

✍ Scribed by Abruzzese, Elisabetta; Breccia, Massimo; Latagliata, Roberto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Generation Tyrosine Kinase Inhibi

✍ Abruzzese, Elisabetta; Breccia, Massimo; Latagliata, Roberto 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 451 KB

Safety profiles of second-line tyrosine

✍ Sara M Tinsley 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

A Comparison of Methodologies for Estima

✍ Pennington, B.; Batty, A.J.; Clifton-Brown, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Outcome After Failure of Second Generati

✍ Eghtedar, Alireza; Kantarjian, Hagop; Jabbour, Elias; O'Brien, Susan; Burton, El 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 439 KB

PCHI4: MEDICAL TREATMENT FOR CHRONIC MYE

✍ MT Groot; GJ Ossenkoppele; MHH Kramer; G van den Boom; PC Huijgens; CA Uyl-de Gr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Tyrosine kinase inhibitors in the treatm

✍ M.W. Drummond; T.L. Holyoake 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 359 KB